SummitTX Capital’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
35,892
-5,245
-13% -$198K 0.04% 386
2026
Q1
$1.47M Buy
41,137
+16,687
+68% +$607K 0.05% 365
2025
Q4
$793K Sell
24,450
-4,730
-16% -$148K 0.02% 452
2025
Q3
$823K Buy
29,180
+16,047
+122% +$460K 0.03% 426
2025
Q2
$396K Sell
13,133
-18,314
-58% -$621K 0.02% 557
2025
Q1
$1.29M Buy
+31,447
New +$1.51M 0.06% 343

Other funds holding CRI

SummitTX Capital's CRI Position: Q2 2026 in Review

SummitTX Capital reduced its Carter's (CRI) stake by 13% in Q2 2026, selling an estimated $198K and leaving 35,892 shares worth $1.48M. The position accounts for 0.04% of the portfolio, ranked #386.

SummitTX Capital first reported a position in CRI in Q1 2025 and has held it in 6 quarters since. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • SummitTX Capital held 35,892 shares of Carter's worth $1.48M as of Q2 2026.
  • SummitTX Capital sold 5,245 Carter's shares in Q2 2026, an estimated $198K.
  • Carter's made up 0.04% of SummitTX Capital's portfolio in Q2 2026, its #386 holding.
  • SummitTX Capital first reported a position in Carter's in Q1 2025 and has held it in 6 quarters since.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.